GlaxoSmithKline filed a federal lawsuit seeking to recoup a share of the tens of billions of dollars in revenue Pfizer and ...

GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...

Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

With its lawsuit filed against Pfizer and BioNTech, the British multinational biopharma has joined the high-profile patent ...

GSK (NYSE:GSK) is reportedly suing Pfizer (PFE) and partner BioNTech (BNTX) for patent infringement over the use of certain ...

GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying ...

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...

The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...

GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the ...

GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV ...

Hello everyone. Welcome to today’s call and webcast. The presentation was sent to our distribution list by email, and you can ...

GlaxoSmithKline (GLAX.NS) sued Pfizer (PFE.N) and BioNTech (22UAy.DE) in Delaware federal court on Thursday, accusing them of ...